OverviewChartProfileKey statisticsFinancialsNewsTraderScreen

Fresenius Medical Care AG/  DE0005785802  /

Cboe Europe DXE
6/20/2025  5:36:15 PM Chg. +0.21 Volume Bid5:36:15 PM Ask5:36:15 PM Market Capitalization Dividend Y. P/E Ratio
46.31EUR +0.46% 271,596
Turnover: 6.03 mill.		 -Bid Size: - -Ask Size: - 13.6 bill.EUR 3.11% 25.33
TeleTrader 6/17 Europe closes lower as Israel-Iran conflict persists
GlobeNewswire 5/28 Halberd, Athena GTX, Inc. & Athena Telemedicine Partnership, LLC Clinical Study Updates
TeleTrader 5/20 European markets close higher after economic data
TeleTrader 4/17 Europe closes mostly lower after ECB rate cut
GlobeNewswire 4/9 Augustine Therapeutics appoints Industry Veteran Pascale Witz as Chair of its Board of Directors
GlobeNewswire 4/9 Augustine Therapeutics appoints Industry Veteran Pascale Witz as Chair of its Board of Directors
TeleTrader 2/14 Europe closes mostly lower amid Munich conference
TeleTrader 2/10 European markets open higher despite US tariff concerns
GlobeNewswire 8/13/2024 CytoSorbents Reports Second Quarter 2024 Financial and Operational Results
GlobeNewswire 6/10/2024 SeaStar Medical Strengthens Board of Directors and Transitions to Commercial-Stage Company
GlobeNewswire 5/16/2024 American Oncology Network Appoints New Board Member
GlobeNewswire 5/10/2024 Humacyte First Quarter 2024 Financial Results and Business Update
GlobeNewswire 5/7/2024 OPKO Health Reports First Quarter 2024 Business Highlights and Financial Results
GlobeNewswire 5/7/2024 Memo Therapeutics increases Series C financing to CHF 45 million
GlobeNewswire 5/7/2024 Memo Therapeutics increases Series C financing to CHF 45 million
GlobeNewswire 4/24/2024 Travere Therapeutics and CSL Vifor Announce European Commission Approves FILSPARI® (sparsentan) for ...
GlobeNewswire 3/14/2024 CytoSorbents Reports Fourth Quarter and Full Year 2023 Results
GlobeNewswire 2/23/2024 Travere Therapeutics and CSL Vifor Announce Sparsentan Receives Positive CHMP Opinion for the Treatm...
GlobeNewswire 2/4/2024 China Medical System (00867） Obtained Exclusive License of a First-line Phosphate-lowering Drug Velp...
GlobeNewswire 1/4/2024 Sigyn Therapeutics Releases Letter to Shareholders
GlobeNewswire 11/9/2023 CytoSorbents Reports Third Quarter 2023 Financial and Operational Results
GlobeNewswire 9/19/2023 ONWARD® Reports 2023 Half Year Results and Business Update
GlobeNewswire 9/4/2023 CIO Leadership: Generative AI and Visionary Leadership in the Enterprise Will Power the Discussion a...
GlobeNewswire 8/31/2023 CytoSorbents Granted Expanded ANVISA Registration to Treat Shock with CytoSorb in Brazil
GlobeNewswire 8/24/2023 CIO Leadership: The Steps Needed to Build a High-Performance Culture Will Power the Discussion at th...